EU tissue engineering sector needs better conditions to thrive
This article was originally published in Clinica
Executive Summary
The current market conditions are challenging - if not hostile - for the EU human tissue engineered products industry. It is a sector where profit margins are squeezed tightly, and companies will not be able to survive (much less thrive) if the obstacles to their progress, including the regulatory fiasco, are not removed.